Annual revenue:
$3.55M+$3.40M(+2250.99%)Summary
- As of today (September 17, 2025), KROS annual revenue is $3.55 million, with the most recent change of +$3.40 million (+2250.99%) on December 31, 2024.
- During the last 3 years, KROS annual revenue has fallen by -$16.55 million (-82.34%).
- KROS annual revenue is now -82.34% below its all-time high of $20.10 million, reached on December 31, 2021.
Performance
KROS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$18.17M-$193.08M(-91.40%)Summary
- As of today (September 17, 2025), KROS quarterly revenue is $18.17 million, with the most recent change of -$193.08 million (-91.40%) on June 30, 2025.
- Over the past year, KROS quarterly revenue has increased by +$18.13 million (+49002.70%).
- KROS quarterly revenue is now -91.40% below its all-time high of $211.25 million, reached on March 31, 2025.
Performance
KROS Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$232.84M+$18.13M(+8.44%)Summary
- As of today (September 17, 2025), KROS TTM revenue is $232.84 million, with the most recent change of +$18.13 million (+8.44%) on June 30, 2025.
- Over the past year, KROS TTM revenue has increased by +$232.57 million (+85820.30%).
- KROS TTM revenue is now at all-time high.
Performance
KROS TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
KROS Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2251.0% | +10000.0% | +10000.0% |
| 3 y3 years | -82.3% | +100.0% | +1064.2% |
| 5 y5 years | -64.5% | +100.0% | +9213.8% |
KROS Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -82.3% | >+9999.0% | -91.4% | >+9999.0% | at high | >+9999.0% |
| 5 y | 5-year | -82.3% | >+9999.0% | -91.4% | >+9999.0% | at high | >+9999.0% |
| alltime | all time | -82.3% | >+9999.0% | -91.4% | >+9999.0% | at high | >+9999.0% |
KROS Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $18.17M(-91.4%) | $232.84M(+8.4%) |
| Mar 2025 | - | $211.25M(+6844.3%) | $214.71M(+5948.3%) |
| Dec 2024 | $3.55M(+2251.0%) | $3.04M(+684.0%) | $3.55M(+445.3%) |
| Sep 2024 | - | $388.00K(+948.6%) | $651.00K(+140.2%) |
| Jun 2024 | - | $37.00K(-55.4%) | $271.00K(+15.8%) |
| Mar 2024 | - | $83.00K(-42.0%) | $234.00K(+55.0%) |
| Dec 2023 | $151.00K(>+9900.0%) | $143.00K(+1687.5%) | $151.00K(+1787.5%) |
| Sep 2023 | - | $8000.00(>+9900.0%) | $8000.00(>+9900.0%) |
| Jun 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2022 | $0.00 | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2022 | - | $0.00(0.0%) | $20.00M(0.0%) |
| Jun 2022 | - | $0.00(0.0%) | $20.00M(-0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $0.00(-100.0%) | $20.10M(0.0%) |
| Dec 2021 | $20.10M(>+9900.0%) | $20.00M(>+9900.0%) | $20.10M(>+9900.0%) |
| Sep 2021 | - | $0.00(-100.0%) | $100.00K(0.0%) |
| Jun 2021 | - | $100.00K(>+9900.0%) | $100.00K(>+9900.0%) |
| Mar 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2020 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2020 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Jun 2020 | - | $0.00(0.0%) | $2.50M(-50.0%) |
| Mar 2020 | - | $0.00(-100.0%) | $5.00M(-33.3%) |
| Dec 2019 | $10.00M(0.0%) | - | - |
| Sep 2019 | - | $2.50M(0.0%) | $7.50M(+50.0%) |
| Jun 2019 | - | $2.50M(0.0%) | $5.00M(+100.0%) |
| Mar 2019 | - | $2.50M | $2.50M |
| Dec 2018 | $10.00M | - | - |
FAQ
- What is Keros Therapeutics, Inc. annual revenue?
- What is the all time high annual revenue for Keros Therapeutics, Inc.?
- What is Keros Therapeutics, Inc. annual revenue year-on-year change?
- What is Keros Therapeutics, Inc. quarterly revenue?
- What is the all time high quarterly revenue for Keros Therapeutics, Inc.?
- What is Keros Therapeutics, Inc. quarterly revenue year-on-year change?
- What is Keros Therapeutics, Inc. TTM revenue?
- What is the all time high TTM revenue for Keros Therapeutics, Inc.?
- What is Keros Therapeutics, Inc. TTM revenue year-on-year change?
What is Keros Therapeutics, Inc. annual revenue?
The current annual revenue of KROS is $3.55M
What is the all time high annual revenue for Keros Therapeutics, Inc.?
Keros Therapeutics, Inc. all-time high annual revenue is $20.10M
What is Keros Therapeutics, Inc. annual revenue year-on-year change?
Over the past year, KROS annual revenue has changed by +$3.40M (+2250.99%)
What is Keros Therapeutics, Inc. quarterly revenue?
The current quarterly revenue of KROS is $18.17M
What is the all time high quarterly revenue for Keros Therapeutics, Inc.?
Keros Therapeutics, Inc. all-time high quarterly revenue is $211.25M
What is Keros Therapeutics, Inc. quarterly revenue year-on-year change?
Over the past year, KROS quarterly revenue has changed by +$18.13M (+49002.70%)
What is Keros Therapeutics, Inc. TTM revenue?
The current TTM revenue of KROS is $232.84M
What is the all time high TTM revenue for Keros Therapeutics, Inc.?
Keros Therapeutics, Inc. all-time high TTM revenue is $232.84M
What is Keros Therapeutics, Inc. TTM revenue year-on-year change?
Over the past year, KROS TTM revenue has changed by +$232.57M (+85820.30%)